Literature DB >> 18838882

Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.

Jergin Chen1, Jonathan D Tward, Dennis C Shrieve, Ying J Hitchcock.   

Abstract

OBJECTIVES: Anaplastic thyroid carcinoma is associated with a high rate of local recurrence and poor prognosis. This analysis examines the effects of surgery and radiotherapy on survival. METHODS AND MATERIALS: Anaplastic thyroid carcinoma patients from the Surveillance, Epidemiology, and End Results database from 1983 to 2002 with > or = 1-month survival after diagnosis who either had surgery performed or recommended were included in the analysis.
RESULTS: Two hundred sixty-one patients met the inclusion criteria for analysis. Median survival was 4 months. Distant or metastatic disease, tumor size >7 cm, and treatment with surgery plus or minus radiotherapy were statistically significant as prognostic for survival on multivariate analysis (P < 0.05). When stratified by extent of disease, the addition of radiotherapy to surgery resulted in improved survival for patients with disease extending into adjacent tissue (P = 0.05); however, patients who had disease confined to the capsule or had further extension or distant metastatic disease did not benefit from radiotherapy after surgery (P > 0.05).
CONCLUSIONS: Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma. Aggressive treatment with surgery and chemoradiation should be encouraged.

Entities:  

Mesh:

Year:  2008        PMID: 18838882     DOI: 10.1097/COC.0b013e31816a61f3

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  44 in total

1.  Dyspnea as a prognostic factor in anaplastic thyroid carcinoma.

Authors:  Lauren Tashima; Ron Mitzner; Saima Durvesh; David Goldenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-20       Impact factor: 2.503

2.  Anaplastic thyroid carcinomas incidentally found on postoperative pathological examination.

Authors:  Akira Yoshida; Kiminori Sugino; Iwao Sugitani; Akira Miyauchi
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

3.  Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

Authors:  Iwao Sugitani; Akira Miyauchi; Kiminori Sugino; Takahiro Okamoto; Akira Yoshida; Shinichi Suzuki
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

4.  Overall Survival of Patients with Aggressive Thyroid Cancer on Fine-Needle Aspiration Biopsy Examination. A Tertiary Romanian Center Experience.

Authors:  Iustina Cosmina Mogos; Dan Alexandru Niculescu; Dumitru Ioachim; Radu Iorgulescu; Catalina Poiana
Journal:  Maedica (Buchar)       Date:  2015-09

Review 5.  Novel approaches in anaplastic thyroid cancer therapy.

Authors:  Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen
Journal:  Oncologist       Date:  2014-09-26

6.  Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.

Authors:  Todd A Pezzi; Abdallah S R Mohamed; Tommy Sheu; Pierre Blanchard; Vlad C Sandulache; Stephen Y Lai; Maria E Cabanillas; Michelle D Williams; Christopher M Pezzi; Charles Lu; Adam S Garden; William H Morrison; David I Rosenthal; Clifton D Fuller; G Brandon Gunn
Journal:  Cancer       Date:  2016-12-27       Impact factor: 6.860

7.  The differences of regulatory networks between papillary and anaplastic thyroid carcinoma: an integrative transcriptomics study.

Authors:  Zongfu Pan; Lu Li; Yangyang Qian; Xinyang Ge; Xiaoping Hu; Yiwen Zhang; Minghua Ge; Ping Huang
Journal:  Cancer Biol Ther       Date:  2020-08-23       Impact factor: 4.742

8.  Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.

Authors:  Sibo Tian; Jeffrey M Switchenko; Teng Fei; Robert H Press; Mustafa Abugideiri; Nabil F Saba; Taofeek K Owonikoko; Amy Y Chen; Jonathan J Beitler; Walter J Curran; Theresa W Gillespie; Kristin A Higgins
Journal:  Head Neck       Date:  2019-12-16       Impact factor: 3.147

9.  The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.

Authors:  Bo Lin; Haiqing Ma; Maoguang Ma; Zhicheng Zhang; Zicheng Sun; I-Yun Hsieh; Okose Okenwa; Haoyan Guan; Jie Li; Weiming Lv
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

10.  Marginal treatment benefit in anaplastic thyroid cancer.

Authors:  Megan R Haymart; Mousumi Banerjee; Huiying Yin; Francis Worden; Jennifer J Griggs
Journal:  Cancer       Date:  2013-07-09       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.